Literature DB >> 1981068

Zuclopenthixol: a new generation of antipsychotic drugs. An open clinical trial.

A M Matar1, M Abdel-Mawgoud, S Skov.   

Abstract

Fifteen patients (20-49 years of age) with mania or acute psychosis were treated with zuclopenthixol acetate (Clopixol, Acuphase). One injection of 75-100 mg produced significant amelioration of psychotic symptoms with minimal side effects. The duration of action of the drug was found to be about 72 hours.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1981068

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  1 in total

1.  An open trial of zuclopenthixol in management of acute psychoses : a multicentered study.

Authors:  J Fernandes; P V Pradhan; P Choudhury; S Chatterji; J Pereira; H Shah; H A Bhinderwala; D M Bhadlikar; R Radhakrishanan
Journal:  Indian J Psychiatry       Date:  1999-07       Impact factor: 1.759

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.